TNF and tuberculosis: Both randomized controlled trials (RCTs) and real-world studies5,6 have implicated tumor necrosis factor inhibitors (TNFis) as increasing the risk of tuberculosis (TB), particularly in patients with a pre-existing latent tuberculosis infection (LTBI).